Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2()

por Hortobagyi, Gabriel N.
Publicado 2015

Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial

por Hortobagyi, Gabriel N.
Publicado 2018

Fingerprinting Lymph Node Metastases

por Symmans, W. Fraser, Hortobagyi, Gabriel N.
Publicado 2008

Inflammatory breast cancer: Clinical progress and the main problems that must be addressed

por Giordano, Sharon H, Hortobagyi, Gabriel N
Publicado 2003

Prognostic molecular markers in early breast cancer

por Esteva, Francisco J, Hortobagyi, Gabriel N
Publicado 2004

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

por Yam, Clinton, Hung, Mien-Chie, Hortobagyi, Gabriel N.
Publicado 2018

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validat...

por Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Publicado 2003

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

por Bartholomeusz, Chandra, Yamasaki, Fumiyuki, Saso, Hitomi, Kurisu, Kaoru, Hortobagyi, Gabriel N., Ueno, Naoto T.
Publicado 2011

John Mendelsohn: A visionary scientist, oncologist and leader

por Kumar, Rakesh, Murad, Ferid, Bogler, Oliver, O'Malley, Bert W., Hortobagyi, Gabriel N.
Publicado 2019

The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells

por Arun, Banu, Akar, Ugur, Gutierrez-Barrera, Angelica M., Hortobagyi, Gabriel N., Ozpolat, Bulent
Publicado 2015

Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment

por Jiang, Zhou, Hsu, Jennifer L., Li, Yintao, Hortobagyi, Gabriel N., Hung, Mien-Chie
Publicado 2020

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer

por de Melo Gagliato, Debora, Leonardo Fontes Jardim, Denis, Marchesi, Mario Sergio Pereira, Hortobagyi, Gabriel N.
Publicado 2016

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes

por Masuda, Hiroko, Qi, Yuan, Liu, Shuying, Hayashi, Naoki, Kogawa, Takahiro, Hortobagyi, Gabriel N., Tripathy, Debu, Ueno, Naoto T.
Publicado 2017

Characterization of bone only metastasis patients with respect to tumor subtypes

por Parkes, Amanda, Clifton, Katherine, Al-Awadhi, Aydah, Oke, Oluchi, Warneke, Carla L., Litton, Jennifer K., Hortobagyi, Gabriel N.
Publicado 2018

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

por Wang, Ying-Nai, Lee, Heng-Huan, Jiang, Zhou, Chan, Li-Chuan, Hortobagyi, Gabriel N., Yu, Dihua, Hung, Mien-Chie
Publicado 2023

Treatment Outcome and Prognostic Factors for Patients with Bone-Only Metastases of Breast Cancer: A Single-Institution Retrospective Analysis

por Niikura, Naoki, Liu, Jun, Hayashi, Naoki, Palla, Shana L., Tokuda, Yutaka, Hortobagyi, Gabriel N., Ueno, Naoto T., Theriault, Richard L.
Publicado 2011

Evaluation of biological pathways involved in chemotherapy response in breast cancer

por Tordai, Attila, Wang, Jing, Andre, Fabrice, Liedtke, Cornelia, Yan, Kai, Sotiriou, Christos, Hortobagyi, Gabriel N, Symmans, W Fraser, Pusztai, Lajos
Publicado 2008

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

por Sohn, Joohyuk, Liu, Shuying, Parinyanitikul, Napa, Lee, Jangsoon, Hortobagyi, Gabriel N., Mills, Gordon B., Ueno, Naoto T., Gonzalez-Angulo, Ana M.
Publicado 2014

Impact of Merit-Based Immigration Policies on Brain Drain From Low- and Middle-Income Countries

por El Saghir, Nagi S., Anderson, Benjamin O., Gralow, Julie, Lopes, Gilberto, Shulman, Lawrence N., Moukadem, Hiba A., Yu, Peter Paul, Hortobagyi, Gabriel
Publicado 2020

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer

por Barcenas, Carlos H., Song, Juhee, Murthy, Rashmi K., Raghavendra, Akshara S., Li, Yisheng, Hsu, Limin, Carlson, Robert W., Tripathy, Debu, Hortobagyi, Gabriel N.
Publicado 2021